The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acq - P2P | Acquired

Total Raised






About MAKO Surgical

MAKO Surgical Corp. is a medical device company that markets its RIO Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and RESTORIS implants for orthopedic procedures called MAKOplasty. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables precise, consistently reproducible bone resection for the accurate insertion and alignment of MAKO's RESTORIS implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications.

MAKO Surgical Headquarter Location

2555 Davie Road

Fort Lauderdale, Florida, 33317,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MAKO Surgical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MAKO Surgical is included in 2 Expert Collections, including Robotics.



1,821 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

MAKO Surgical Patents

MAKO Surgical has filed 353 patents.

The 3 most popular patent topics include:

  • Surgery
  • Orthopedic surgical procedures
  • Surgical instruments
patents chart

Application Date

Grant Date


Related Topics




Automotive transmission technologies, Gears, Mechanisms (engineering), Automobile transmissions, Mechanical power transmission


Application Date


Grant Date



Related Topics

Automotive transmission technologies, Gears, Mechanisms (engineering), Automobile transmissions, Mechanical power transmission



Latest MAKO Surgical News

Catching up with Neocis’ Alon Mozes: A Miami success story is unfolding

Mar 4, 2022

Catching up with Neocis' Alon Mozes: A Miami success story is unfolding Catching up with Neocis’ Alon Mozes: A Miami success story is unfolding The latest news: The Miami medtech startup will soon have a 38,000-square-foot HQ in Wynwood, tripling its current space. There are easier entrepreneurial roads to take than pioneering robot-assisted dental implant surgery, but Miami-based startup Neocis is today the leader in the field. CEO Alon Mozes and his team developed the first and only FDA-cleared robot, Yomi,  that is certainly up to the task, having placed more than 10,000 dental implants to date. The last time we checked in with Mozes, Neocis had just raises a $72 million Series D round  and was poised to put that money to work on commercialization. This week he is announcing that Neocis has signed a new lease for 38,000 square feet of office space at 545wyn in Miami’s Wynwood neighborhood, with a planned move-in this fall after buildout. 545wyn Currently, the 140-employee company is based in two office spaces in Miami area, one for engineering and administration functions and a warehouse for manufacturing and quality assurance. “That separation is an impediment to being able to move faster and build really high quality product at a really very fast pace,” Mozes said. The new HQ will also be triple the size of the two current spaces together, which will come in handy because Mozes projects the team will be 200-strong by the end of the year. To put that growth in perspective, in 2016, the team was 10, in 2020 the count was up to 70, and now double that, Mozes said. “The new officers will be an opportunity to bring all those departments under one roof. So for example, we’ll have engineering and manufacturing that really work well when they’re under the same roof and can work together.” Since closing that round of funding in 2020, Neocis hired a Chief Commercial Officer, Wayne Craig, who has deep background in dental and robotic surgery. Craig has now put in place a fully built out sales team selling robots and managing the accounts to help drive utilization. “We have a lot of practices that now they won’t do an implant procedure without our robot,” Mozes said. To date, over 140 dental surgeons have used Yomi to place more than 10,000 implants. Yomi allows dentists to precisely pre-plan the dental implant procedure and then guides their hand during the surgery according to the pre-operative plan by using haptic robotic feedback. Because of the increased accuracy and digital planning provided by Yomi, dentists can operate with a smaller incision. For patients, that means less pain and faster recoveries. Neocis’ Yomi “Passing that 10,000 implant mark is a sign that we’re transitioning from that early stage startup to a real growth-stage company with various successful commercial efforts,” Mozes said. What’s more, R&D is full-speed ahead with efforts such as adding indications for more complicated procedures such as so-called full arch replacements. “We’re never just sitting back and resting. We’re always making the system better, making it easier to use, and expanding its functionality so it can do more and more in the practices.” Neocis, co-founded by Mozes and Juan Salcedo, is a very Miami story . Mozes grew up in South Florida, and after getting his bachelor’s and master’s in engineering at MIT, he got his start in Silicon Valley working for an innovator in special effects for sports broadcasts. In 2004, he returned to Miami to study biomedical engineering at the University of Miami, earning his Ph.D. In 2005, Mozes became one of the first 20 employees at Mako Surgical, working there through Mako’s IPO. Mozes and Salcedo, both engineers who met while working at Mako, had been working on their idea for Neocis on the side, and in 2012 they landed their first angel money from robotics pioneer Fred Moll. They are part of a network of former Mako leaders and employees who have gone on to form or grow other ventures in South Florida, including Magic Leap, OrthoSensor, Insightec and DermaSensor. What’s ahead for Neocis? Continued growth on the sales front. As for R&D, the team has more than 40 world-class engineers now. “We’re going to keep accelerating on creating new indications and new value, which in turn creates that flywheel effect and helps sell more systems.” Neocis is hiring for almost every department, including engineering, product management, quality assurance, regulatory affairs,  and manufacturing. Mozes said Neocis is considering raising a Series E. So far, Neocis has raised $122.9 million, according to Crunchbase. Follow Nancy Dahlberg on Twitter @ndahlberg and email her at [email protected]

  • When was MAKO Surgical founded?

    MAKO Surgical was founded in 1997.

  • Where is MAKO Surgical's headquarters?

    MAKO Surgical's headquarters is located at 2555 Davie Road, Fort Lauderdale.

  • What is MAKO Surgical's latest funding round?

    MAKO Surgical's latest funding round is Acq - P2P.

  • How much did MAKO Surgical raise?

    MAKO Surgical raised a total of $57.01M.

  • Who are the investors of MAKO Surgical?

    Investors of MAKO Surgical include Stryker, Sycamore Ventures, Highbridge Capital Management, Lumira Ventures, Aperture Venture Partners and 8 more.

  • Who are MAKO Surgical's competitors?

    Competitors of MAKO Surgical include ACTIV Surgical, Tepha, Wright Medical Group, Orthoscan, Celonova Biosciences, LifeBond, Intellirod Spine, Paragon Medical, Apollo Endosurgery, The Foundry Visionmongers and 33 more.

You May Also Like


iBalance, Inc. is developing an improved method for completing an orthopedic surgical procedure called high tibial osteotomy. The company aims to provide the surgical tools and implant for this knee malalignment corrective surgery.

TransCorp Logo

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures


Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.

SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.


SpineForm is developing a less invasive spinal deformity surgical treatment. SpineForm's HemiBridge is a spinal implant designed to help correct and straighten spinal deformities in growing children, without the need for a brace or extensive future spinal fusion surgeries.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.